Hydroxocobalamin and Trimethoprim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxocobalamin (hydroxocobalamin) and Trimethoprim (trimethoprim). Common drug interactions include neutropenic sepsis among females and aphthous stomatitis among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxocobalamin and Trimethoprim. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

What is Trimethoprim?

Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 8,213 Trimethoprim users. Check the latest studies of Trimethoprim.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

85 people who take Hydroxocobalamin and Trimethoprim together, and have interactions are studied.

Hydroxocobalamin and Trimethoprim drug interactions.

What are the common drug interactions of Hydroxocobalamin and Trimethoprim, by gender? *:

female:

  1. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Arthralgia (joint pain)
  9. Rash
  10. Bone pain

male:

  1. Aphthous stomatitis (mouth ulcer)
  2. Myalgia (muscle pain)
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. Fatigue (feeling of tiredness)
  5. Haematuria (presence of blood in urine)
  6. Haemorrhage (bleeding)
  7. Headache (pain in head)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Ischaemic cerebral infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain)

What are the common drug interactions of Hydroxocobalamin and Trimethoprim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. C-reactive protein increased
  4. Cancer pain
  5. Diarrhoea
  6. Mucosal inflammation (infection of mucous membrane)
  7. Oedema peripheral (superficial swelling)
  8. Vomiting
  9. Wound
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

  1. Dry Skin: 24 people, 28.24%
  2. Wound: 22 people, 25.88%
  3. Skin Ulcer: 22 people, 25.88%
  4. Breast Cancer Metastatic: 22 people, 25.88%
  5. Cellulitis (infection under the skin): 22 people, 25.88%
  6. Fever: 22 people, 25.88%
  7. Abdominal Hernia Obstructive (abdominal hernia causing a blockage): 22 people, 25.88%
  8. Joint Pain: 22 people, 25.88%
  9. Oedema Peripheral (superficial swelling): 22 people, 25.88%
  10. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 17 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and Trimethoprim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydroxocobalamin and Trimethoprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trimethoprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trimethoprim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin and trimethoprim (the active ingredients of Hydroxocobalamin and Trimethoprim, respectively), and Hydroxocobalamin and Trimethoprim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: